BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mirzoyev SA, Schrum AG, Davis MDP, Torgerson RR. Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009. J Invest Dermatol. 2014;134:1141-1142. [PMID: 24202232 DOI: 10.1038/jid.2013.464] [Cited by in Crossref: 106] [Cited by in F6Publishing: 81] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Darwin E, Arora H, Hirt PA, Wikramanayake TC, Jimenez JJ. A review of monochromatic light devices for the treatment of alopecia areata. Lasers Med Sci 2018;33:435-44. [PMID: 29250710 DOI: 10.1007/s10103-017-2412-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
2 Gilhar A, Schrum AG, Etzioni A, Waldmann H, Paus R. Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies. Autoimmun Rev 2016;15:726-35. [PMID: 26971464 DOI: 10.1016/j.autrev.2016.03.008] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 9.6] [Reference Citation Analysis]
3 Fischer J, Degenhardt F, Hofmann A, Redler S, Basmanav FB, Heilmann-Heimbach S, Hanneken S, Giehl KA, Wolff H, Moebus S, Kruse R, Lutz G, Blaumeiser B, Böhm M, Garcia Bartels N, Blume-Peytavi U, Petukhova L, Christiano AM, Nöthen MM, Betz RC. Genomewide analysis of copy number variants in alopecia areata in a Central European cohort reveals association with MCHR2. Exp Dermatol 2017;26:536-41. [PMID: 27306922 DOI: 10.1111/exd.13123] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
4 Alshahrani AA, Al-Tuwaijri R, Abuoliat ZA, Alyabsi M, AlJasser MI, Alkhodair R. Prevalence and Clinical Characteristics of Alopecia Areata at a Tertiary Care Center in Saudi Arabia. Dermatol Res Pract 2020;2020:7194270. [PMID: 32231700 DOI: 10.1155/2020/7194270] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
5 Thompson JM, Park MK, Qureshi AA, Cho E. Race and Alopecia Areata amongst US Women. Journal of Investigative Dermatology Symposium Proceedings 2018;19:S47-50. [DOI: 10.1016/j.jisp.2017.10.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Burns LJ, Mesinkovska N, Kranz D, Ellison A, Senna MM. Cumulative Life Course Impairment of Alopecia Areata. Int J Trichology 2020;12:197-204. [PMID: 33531741 DOI: 10.4103/ijt.ijt_99_20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Han TY, Lee JH, Noh TK, Choi MW, Yun JS, Lee KH, Bae JM. Alopecia areata and overt thyroid diseases: A nationwide population-based study. J Dermatol 2018;45:1411-7. [PMID: 30222206 DOI: 10.1111/1346-8138.14648] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Wipf A, Boysen N, Hordinsky MK, Dando EE, Sadick N, Farah RS. The rise of transcutaneous drug delivery for the management of alopecia: a review of existing literature and an eye towards the future. J Cosmet Laser Ther 2019;21:247-54. [PMID: 30300013 DOI: 10.1080/14764172.2018.1525743] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
9 Burroway B, Griggs J, Tosti A. Alopecia totalis and universalis long‐term outcomes: a review. J Eur Acad Dermatol Venereol 2020;34:709-15. [DOI: 10.1111/jdv.15994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Davey L, Clarke V, Jenkinson E. Living with alopecia areata: an online qualitative survey study. Br J Dermatol 2019;180:1377-89. [PMID: 30501016 DOI: 10.1111/bjd.17463] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
11 Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, Shapiro J. Alopecia areata. Journal of the American Academy of Dermatology 2018;78:1-12. [DOI: 10.1016/j.jaad.2017.04.1141] [Cited by in Crossref: 108] [Cited by in F6Publishing: 74] [Article Influence: 36.0] [Reference Citation Analysis]
12 Lee HH, Gwillim E, Patel KR, Hua T, Rastogi S, Ibler E, Silverberg JI. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis. J Am Acad Dermatol 2020;82:675-82. [PMID: 31437543 DOI: 10.1016/j.jaad.2019.08.032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
13 Chen CC, Chang YT, Liu HN, Chen YJ. Cancer risk in patients with alopecia areata: a nationwide population-based matched cohort study. Cancer Med 2018;7:2153-9. [PMID: 29577672 DOI: 10.1002/cam4.1448] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
14 Tzur Bitan D, Berzin D, Kridin K, Cohen A. The association between alopecia areata and anxiety, depression, schizophrenia, and bipolar disorder: a population-based study. Arch Dermatol Res 2021. [PMID: 34089375 DOI: 10.1007/s00403-021-02247-6] [Reference Citation Analysis]
15 Ahn H, Lee SY, Jung WJ, Lee KH. Alopecia treatment using minimally manipulated human umbilical cord-derived mesenchymal stem cells: Three case reports and review of literature. World J Clin Cases 2021;9:3741-51. [PMID: 34046478 DOI: 10.12998/wjcc.v9.i15.3741] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Benigno M, Anastassopoulos KP, Mostaghimi A, Udall M, Daniel SR, Cappelleri JC, Chander P, Wahl PM, Lapthorn J, Kauffman L, Chen L, Peeva E. A Large Cross-Sectional Survey Study of the Prevalence of Alopecia Areata in the United States. Clin Cosmet Investig Dermatol 2020;13:259-66. [PMID: 32280257 DOI: 10.2147/CCID.S245649] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
17 Olsen EA, Roberts J, Sperling L, Tosti A, Shapiro J, McMichael A, Bergfeld W, Callender V, Mirmirani P, Washenik K, Whiting D, Cotsarelis G, Hordinsky M. Objective outcome measures: Collecting meaningful data on alopecia areata. J Am Acad Dermatol 2018;79:470-478.e3. [PMID: 29128463 DOI: 10.1016/j.jaad.2017.10.048] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
18 Majid I, Sameem F, Sultan J, Aleem S. Alopecia areata severity index (AASI): A reliable scoring system to assess the severity of alopecia areata on face and scalp-a pilot study. J Cosmet Dermatol 2021;20:2565-70. [PMID: 34129730 DOI: 10.1111/jocd.14289] [Reference Citation Analysis]
19 Rajoo Y, Wong J, Cooper G, Raj IS, Castle DJ, Chong AH, Green J, Kennedy GA. The relationship between physical activity levels and symptoms of depression, anxiety and stress in individuals with alopecia Areata. BMC Psychol 2019;7:48. [PMID: 31337438 DOI: 10.1186/s40359-019-0324-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Petukhova L, Patel AV, Rigo RK, Bian L, Verbitsky M, Sanna-Cherchi S, Erjavec SO, Abdelaziz AR, Cerise JE, Jabbari A, Christiano AM. Integrative analysis of rare copy number variants and gene expression data in alopecia areata implicates an aetiological role for autophagy. Exp Dermatol 2020;29:243-53. [PMID: 31169925 DOI: 10.1111/exd.13986] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
21 Fuentes-Duculan J, Gulati N, Bonifacio KM, Kunjravia N, Zheng X, Suárez-Fariñas M, Shemer A, Guttman-Yassky E, Krueger JG. Biomarkers of alopecia areata disease activity and response to corticosteroid treatment. Exp Dermatol 2016;25:282-6. [PMID: 26661294 DOI: 10.1111/exd.12918] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
22 Kuin R, Spuls P, Limpens J, van Zuuren EJ. Diphenylcyclopropenone in patients with alopecia areata. A critically appraised topic. Br J Dermatol 2015;173:896-909. [DOI: 10.1111/bjd.14040] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
23 Bain KA, McDonald E, Moffat F, Tutino M, Castelino M, Barton A, Cavanagh J, Ijaz UZ, Siebert S, McInnes IB, Astrand A, Holmes S, Milling SWF. Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity. Br J Dermatol 2020;182:130-7. [PMID: 30980732 DOI: 10.1111/bjd.18008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
24 Simakou T, Butcher JP, Reid S, Henriquez FL. Alopecia areata: A multifactorial autoimmune condition. J Autoimmun. 2019;98:74-85. [PMID: 30558963 DOI: 10.1016/j.jaut.2018.12.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 9.3] [Reference Citation Analysis]
25 Richard M, Corgibet F, Beylot‐barry M, Barbaud A, Bodemer C, Chaussade V, D'incan M, Joly P, Leccia M, Meurant J, Petit A, Geffroy BR, Sei J, Taieb C, Misery L, Ezzedine K. Sex‐ and age‐adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the « OBJECTIFS PEAU » study. J Eur Acad Dermatol Venereol 2018;32:1967-71. [DOI: 10.1111/jdv.14959] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 11.7] [Reference Citation Analysis]
26 Manimaran RP, Ramassamy S, Rajappa M, Chandrashekar L. Therapeutic outcome of diphencyprone and its correlation with serum cytokine profile in alopecia areata. J Dermatolog Treat 2020;:1-5. [PMID: 32249656 DOI: 10.1080/09546634.2020.1752887] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
27 Ismail FF, Sinclair R. JAK inhibition in the treatment of alopecia areata – a promising new dawn? Expert Review of Clinical Pharmacology 2020;13:43-51. [DOI: 10.1080/17512433.2020.1702878] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
28 Waśkiel A, Rakowska A, Sikora M, Olszewska M, Rudnicka L. Trichoscopy of alopecia areata: An update. J Dermatol 2018;45:692-700. [DOI: 10.1111/1346-8138.14283] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 9.3] [Reference Citation Analysis]
29 Janković S, Perić J, Maksimović N, Ćirković A, Marinković J, Janković J, Reljić V, Medenica L. Quality of life in patients with alopecia areata: a hospital-based cross-sectional study. J Eur Acad Dermatol Venereol 2016;30:840-6. [DOI: 10.1111/jdv.13520] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
30 Wang EHC, Yu M, Breitkopf T, Akhoundsadegh N, Wang X, Shi FT, Leung G, Dutz JP, Shapiro J, McElwee KJ. Identification of Autoantigen Epitopes in Alopecia Areata. J Invest Dermatol 2016;136:1617-26. [PMID: 27094591 DOI: 10.1016/j.jid.2016.04.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 6.2] [Reference Citation Analysis]
31 de Oliveira AB, Alpalhão M, Filipe P, Maia-Silva J. The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review. Dermatol Ther 2019;32:e13053. [PMID: 31381252 DOI: 10.1111/dth.13053] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
32 Villasante Fricke AC, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol 2015;8:397-403. [PMID: 26244028 DOI: 10.2147/CCID.S53985] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
33 Kanameishi S, Dainichi T, Endo Y, Otsuka A, Tanioka M, Kabashima K. Successful hair regrowth in an acute diffuse form of alopecia areata during oral tacrolimus treatment in a patient with rheumatoid arthritis. J Eur Acad Dermatol Venereol 2017;31:e137-8. [PMID: 27532876 DOI: 10.1111/jdv.13879] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
34 Liu LY, King BA, Craiglow BG. Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review. J Am Acad Dermatol 2016;75:806-812.e3. [PMID: 27436156 DOI: 10.1016/j.jaad.2016.04.035] [Cited by in Crossref: 59] [Cited by in F6Publishing: 46] [Article Influence: 11.8] [Reference Citation Analysis]
35 Darwin E, Hirt PA, Fertig R, Doliner B, Delcanto G, Jimenez JJ. Alopecia Areata: Review of Epidemiology, Clinical Features, Pathogenesis, and New Treatment Options. Int J Trichology 2018;10:51-60. [PMID: 29769777 DOI: 10.4103/ijt.ijt_99_17] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 13.3] [Reference Citation Analysis]
36 Antoury L, Maloney NJ, Bach DQ, Goh C, Cheng K. Alopecia areata as an immune‐related adverse event of immune checkpoint inhibitors: A review. Dermatologic Therapy 2020;33. [DOI: 10.1111/dth.14171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Andersen LK, Davis MD. Sex differences in the incidence of skin and skin-related diseases in Olmsted County, Minnesota, United States, and a comparison with other rates published worldwide. Int J Dermatol 2016;55:939-55. [PMID: 27009931 DOI: 10.1111/ijd.13285] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 4.4] [Reference Citation Analysis]
38 Olsen EA, Kornacki D, Sun K, Hordinsky MK. Ruxolitinib cream for the treatment of patients with alopecia areata: A 2-part, double-blind, randomized, vehicle-controlled phase 2 study. J Am Acad Dermatol 2020;82:412-9. [PMID: 31622643 DOI: 10.1016/j.jaad.2019.10.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
39 Ho AW, Kupper TS. T cells and the skin: from protective immunity to inflammatory skin disorders. Nat Rev Immunol 2019;19:490-502. [DOI: 10.1038/s41577-019-0162-3] [Cited by in Crossref: 61] [Cited by in F6Publishing: 46] [Article Influence: 30.5] [Reference Citation Analysis]
40 Fagan N, Meah N, York K, Bokhari L, Fletcher G, Chen G, Tobin DJ, Messenger A, Irvine AD, Sinclair R, Wall D. Shedding light on therapeutics in alopecia and their relevance to COVID-19. Clin Dermatol 2021;39:76-83. [PMID: 33972056 DOI: 10.1016/j.clindermatol.2020.12.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Waśkiel‐burnat A, Rakowska A, Sikora M, Olszewska M, Rudnicka L. Alopecia areata predictive score: A new trichoscopy‐based tool to predict treatment outcome in patients with patchy alopecia areata. J Cosmet Dermatol 2019;19:746-51. [DOI: 10.1111/jocd.13064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Tang G, Xiong J, Fan Q, Guo H, Zhou X, Zhu S, Zhong Z, Chen J, Lu L. Plum-blossom needle plus Chinese herbal medicine for alopecia areata: A protocol for systematic review and meta analysis. Medicine (Baltimore) 2020;99:e22515. [PMID: 33031290 DOI: 10.1097/MD.0000000000022515] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Ghanizadeh A, Ayoobzadehshirazi A. A review of psychiatric disorders comorbidities in patients with alopecia areata. Int J Trichology 2014;6:2-4. [PMID: 25114444 DOI: 10.4103/0974-7753.136746] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
44 Zimmermann J, Buhl T, Müller M. Alopecia Universalis following Alemtuzumab Treatment in Multiple Sclerosis: A Barely Recognized Manifestation of Secondary Autoimmunity-Report of a Case and Review of the Literature. Front Neurol 2017;8:569. [PMID: 29163335 DOI: 10.3389/fneur.2017.00569] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
45 Lyakhovitsky A, Aronovich A, Gilboa S, Baum S, Barzilai A. Alopecia areata: a long-term follow-up study of 104 patients. J Eur Acad Dermatol Venereol 2019;33:1602-9. [PMID: 30887594 DOI: 10.1111/jdv.15582] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
46 Turkmen D, Altunisik N, Sener S, Colak C. Evaluation of the effects of COVID-19 pandemic on hair diseases through a web-based questionnaire. Dermatol Ther 2020;33:e13923. [PMID: 32594627 DOI: 10.1111/dth.13923] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
47 Guo L, Feng S, Sun B, Jiang X, Liu Y. Benefit and risk profile of tofacitinib for the treatment of alopecia areata: a systemic review and meta‐analysis. J Eur Acad Dermatol Venereol 2019;34:192-201. [DOI: 10.1111/jdv.15937] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
48 Yoon HS, Bae JM, Yeom SD, Sim W, Lee WS, Kang H, Lee YW, Kim K, Kim D, Kim M, Kim S, Lew B, Kwon OS, Huh CH, Lee D, Ro BI, Park J, Kim BJ, Lee Y, Choi GS. Factors Affecting the Psychosocial Distress of Patients with Alopecia Areata: A Nationwide Study in Korea. Journal of Investigative Dermatology 2019;139:712-5. [DOI: 10.1016/j.jid.2018.09.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Arousse A, Boussofara L, Mokni S, Gammoudi R, Saidi W, Aounallah A, Belajouza C, Ghariani N, Denguezli M, Nouira R. Alopecia areata in Tunisia: epidemio-clinical aspects and comorbid conditions. A prospective study of 204 cases. Int J Dermatol 2019;58:811-5. [PMID: 30677128 DOI: 10.1111/ijd.14381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Lee H, Jung SJ, Patel AB, Thompson JM, Qureshi A, Cho E. Racial characteristics of alopecia areata in the United States. J Am Acad Dermatol 2020;83:1064-70. [PMID: 31279016 DOI: 10.1016/j.jaad.2019.06.1300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Gupta AK, Renaud HJ, Rapaport JA. Platelet-rich Plasma and Cell Therapy: The New Horizon in Hair Loss Treatment. Dermatol Clin 2021;39:429-45. [PMID: 34053596 DOI: 10.1016/j.det.2021.04.001] [Reference Citation Analysis]
52 Savaş Erdoğan S, Falay Gür T, Doğan B. Anxiety and depression in pediatric patients with vitiligo and alopecia areata and their parents: A cross-sectional controlled study. J Cosmet Dermatol 2021;20:2232-9. [PMID: 33089618 DOI: 10.1111/jocd.13807] [Reference Citation Analysis]
53 Hayran Y, Gunindi Korkut M, Öktem A, Şen O, Gür Aksoy G, Özmen F. Evaluation of HLA class I and HLA class II allele profile and its relationship with clinical features in patients with alopecia areata: a case-control study. J Dermatolog Treat 2021;:1-7. [PMID: 34057862 DOI: 10.1080/09546634.2021.1937478] [Reference Citation Analysis]
54 Ho HY, Wong CK, Wu SY, Hsiao RC, Chen YL, Yen CF. Increased Alopecia Areata Risk in Children with Attention-Deficit/Hyperactivity Disorder and the Impact of Methylphenidate Use: A Nationwide Population-Based Cohort Study. Int J Environ Res Public Health 2021;18:1286. [PMID: 33535410 DOI: 10.3390/ijerph18031286] [Reference Citation Analysis]
55 Pratt CH, King LE Jr, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers 2017;3:17011. [PMID: 28300084 DOI: 10.1038/nrdp.2017.11] [Cited by in Crossref: 140] [Cited by in F6Publishing: 101] [Article Influence: 35.0] [Reference Citation Analysis]
56 Nasimi M, Abedini R, Ghandi N, Manuchehr F, Kazemzadeh Houjaghan A, Shakoei S. Illness perception in patients with Alopecia areata under topical immunotherapy. Dermatol Ther 2021;34:e14748. [PMID: 33403745 DOI: 10.1111/dth.14748] [Reference Citation Analysis]
57 Kinoshita‐ise M, Martinez‐cabriales SA, Alhusayen R. Chronological association between alopecia areata and autoimmune thyroid diseases: A systematic review and meta‐analysis. J Dermatol 2019;46:702-9. [DOI: 10.1111/1346-8138.14940] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Lee W, Shen S, Aljuffali IA, Li Y, Fang J. Erbium–Yttrium–Aluminum–Garnet Laser Irradiation Ameliorates Skin Permeation and Follicular Delivery of Antialopecia Drugs. Journal of Pharmaceutical Sciences 2014;103:3542-52. [DOI: 10.1002/jps.24143] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
59 Korona-Bailey J, Banaag A, Nguyen DR, Pasieka H, Koehlmoos TP. Free the Bun: Prevalence of Alopecia Among Active Duty Service Women, Fiscal Years 2010-2019. Mil Med 2021:usab274. [PMID: 34244770 DOI: 10.1093/milmed/usab274] [Reference Citation Analysis]
60 Almohanna HM, Ahmed AA, Griggs JW, Tosti A. Platelet-Rich Plasma in the Treatment of Alopecia Areata: A Review. J Investig Dermatol Symp Proc. 2020;20:S45-S49. [PMID: 33099384 DOI: 10.1016/j.jisp.2020.05.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
61 Guo H, Cheng Y, Shapiro J, McElwee K. The role of lymphocytes in the development and treatment of alopecia areata. Expert Rev Clin Immunol 2015;11:1335-51. [PMID: 26548356 DOI: 10.1586/1744666X.2015.1085306] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
62 Soh BW, Kim SM, Kim YC, Choi GS, Choi JW. Increasing prevalence of alopecia areata in South Korea. J Dermatol 2019;46. [DOI: 10.1111/1346-8138.14863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Dabek RJ, Roh DS, Ozdemir D, Austen WG Jr, Bojovic B. Fractional Laser-assisted Hair Regrowth and Microneedling for the Treatment of Alopecia Areata: A Review. Cureus 2019;11:e4943. [PMID: 31453018 DOI: 10.7759/cureus.4943] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Jun M, Lee WS. Therapeutic Effect of Superficial Cryotherapy on Alopecia Areata: A Prospective, Split-scalp Study in Patients with Multiple Alopecia Patches. Ann Dermatol 2017;29:722-7. [PMID: 29200760 DOI: 10.5021/ad.2017.29.6.722] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Bae JM, Kim M, Lee HH, Kim K, Shin H, Ju HJ, Kim GM, Park CJ, Park HJ. Increased Risk of Vitiligo Following Anti-Tumor Necrosis Factor Therapy: A 10-Year Population-Based Cohort Study. Journal of Investigative Dermatology 2018;138:768-74. [DOI: 10.1016/j.jid.2017.11.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
66 Kagami S, Kishi Y, Hino H. Topical immunotherapy in combination with anthralin in the treatment of refractory alopecia areata. J Cosmet Dermatol 2020;19:2411-4. [PMID: 32621407 DOI: 10.1111/jocd.13588] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Aldhouse NVJ, Kitchen H, Knight S, Macey J, Nunes FP, Dutronc Y, Mesinkovska N, Ko JM, King BA, Wyrwich KW. "'You lose your hair, what's the big deal?' I was so embarrassed, I was so self-conscious, I was so depressed:" a qualitative interview study to understand the psychosocial burden of alopecia areata. J Patient Rep Outcomes 2020;4:76. [PMID: 32914253 DOI: 10.1186/s41687-020-00240-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
68 Christmann R, Ho DK, Wilzopolski J, Lee S, Koch M, Loretz B, Vogt T, Bäumer W, Schaefer UF, Lehr CM. Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases. Pharmaceutics 2020;12:E1131. [PMID: 33255225 DOI: 10.3390/pharmaceutics12121131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
69 Barrón-hernández YL, Tosti A. Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia. Expert Opinion on Investigational Drugs 2017;26:515-22. [DOI: 10.1080/13543784.2017.1303480] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
70 Amirnia M, Mahmoudi SS, Karkon-Shayan F, Alikhah H, Piri R, Naghavi-Behzad M, Ranjkesh MR. Comparative study of intralesional steroid injection and cryotherapy in alopecia areata. Niger Med J 2015;56:249-52. [PMID: 26759508 DOI: 10.4103/0300-1652.165034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
71 Huang KP, Joyce CJ, Topaz M, Guo Y, Mostaghimi A. Cardiovascular risk in patients with alopecia areata (AA): A propensity-matched retrospective analysis. Journal of the American Academy of Dermatology 2016;75:151-4. [DOI: 10.1016/j.jaad.2016.02.1234] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
72 Dainichi T, Kabashima K. Alopecia areata: What's new in epidemiology, pathogenesis, diagnosis, and therapeutic options? J Dermatol Sci 2017;86:3-12. [PMID: 27765435 DOI: 10.1016/j.jdermsci.2016.10.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
73 Ramos PM, Anzai A, Duque-Estrada B, Melo DF, Sternberg F, Santos LDN, Alves LD, Mulinari-Brenner F. Consensus on the treatment of alopecia areata - Brazilian Society of Dermatology. An Bras Dermatol 2020;95 Suppl 1:39-52. [PMID: 33183894 DOI: 10.1016/j.abd.2020.05.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Murad A, Maguire J, Bergfeld W. Drug-induced alopecia areata? Clin Exp Dermatol 2021;46:363-6. [PMID: 32681530 DOI: 10.1111/ced.14381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Mathes C, Melero A, Conrad P, Vogt T, Rigo L, Selzer D, Prado W, De Rossi C, Garrigues T, Hansen S, Guterres S, Pohlmann A, Beck R, Lehr C, Schaefer U. Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects. Journal of Controlled Release 2016;223:207-14. [DOI: 10.1016/j.jconrel.2015.12.010] [Cited by in Crossref: 45] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
76 İslamoğlu ZGK, Unal M. Is there an association of ABO blood groups and Rhesus factor with alopecia areata? J Cosmet Dermatol 2018;17:1271-4. [DOI: 10.1111/jocd.12491] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Vañó-Galván S, Saceda-Corralo D, Blume-Peytavi U, Cucchía J, Dlova NC, Gavazzoni Dias MFR, Grimalt R, Guzmán-Sánchez D, Harries M, Ho A, Holmes S, Larrondo J, Mosam A, Oliveira-Soares R, Pinto GM, Piraccini BM, Pirmez R, De la Rosa Carrillo D, Rudnicka L, Shapiro J, Sinclair R, Tosti A, Trüeb RM, Vogt A, Miteva M. Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study. Skin Appendage Disord 2019;5:309-15. [PMID: 31559256 DOI: 10.1159/000496708] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 10.5] [Reference Citation Analysis]
78 Seo H, Kim TL, Kim JS. The risk of alopecia areata and other related autoimmune diseases in patients with sleep disorders: a Korean population–based retrospective cohort study. Sleep 2018;41. [DOI: 10.1093/sleep/zsy111] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
79 Rajabi F, Drake LA, Senna MM, Rezaei N. Alopecia areata: a review of disease pathogenesis. Br J Dermatol 2018;179:1033-48. [PMID: 29791718 DOI: 10.1111/bjd.16808] [Cited by in Crossref: 53] [Cited by in F6Publishing: 37] [Article Influence: 17.7] [Reference Citation Analysis]
80 Wessman LL, Andersen LK, Davis MDP. Incidence of diseases primarily affecting the skin by age group: population-based epidemiologic study in Olmsted County, Minnesota, and comparison with age-specific incidence rates worldwide. Int J Dermatol 2018;57:1021-34. [PMID: 29377079 DOI: 10.1111/ijd.13904] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
81 Rajabi F, Amoli MM, Robati RM, Almasi-nasrabadi M, Jabalameli N. Macrophage migration inhibitory factor polymorphism (rs755622) in alopecia areata: a possible role in disease prevention. Arch Dermatol Res 2019;311:589-94. [DOI: 10.1007/s00403-019-01934-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]